Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) Peptide
PLA2G4B
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939674
Quick Overview for Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) Peptide (ABIN939674)
Target
PLA2G4B
(Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- KDHYENLYCV VSGEKHFLFH PPSDRPFIPY ELYTPATYQL TEEGTFKVVD
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PLA2 G2 antibody,
Alternative Names: PLA2G4B control peptide, PLA2G4B antibody Blocking Peptide, Anti-PLA2G4B Blocking Peptide, phospholipase A2, group IVB, cytosolic Blocking Peptide, FLJ42498 Blocking Peptide, HsT16992 Blocking Peptide, cPLA2-beta Blocking Peptide, PLA2G4B, PLAG4B-2, PLAG4B 2, PLAG4B-2 Blocking Peptide, PLAG4B 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Background
- This gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD).
-
Molecular Weight
- 114 kDa
Target
-
You are here:
